A comparative analysis of the substrate permissiveness of HCV and GBV-B NS3/4A proteases reveals genetic evidence for an interaction with NS4B protein during genome replication
- PMID: 20701941
- DOI: 10.1016/j.virol.2010.07.014
A comparative analysis of the substrate permissiveness of HCV and GBV-B NS3/4A proteases reveals genetic evidence for an interaction with NS4B protein during genome replication
Abstract
The hepatitis C virus (HCV) serine protease (NS3/4A) processes the NS3-NS5B segment of the viral polyprotein and also cleaves host proteins involved in interferon signaling, making it an important target for antiviral drug discovery and suggesting a wide breadth of substrate specificity. We compared substrate specificities of the HCV protease with that of the GB virus B (GBV-B), a distantly related nonhuman primate hepacivirus, by exchanging amino acid sequences at the NS4B/5A and/or NS5A/5B cleavage junctions between these viruses within the backbone of subgenomic replicons. This mutagenesis study demonstrated that the GBV-B protease had a broader substrate tolerance, a feature corroborated by structural homology modeling. However, despite efficient polyprotein processing, GBV-B RNAs containing HCV sequences at the C-terminus of NS4B had a pseudo-lethal replication phenotype. Replication-competent revertants contained second-site substitutions within the NS3 protease or NS4B N-terminus, providing genetic evidence for an essential interaction between NS3 and NS4B during genome replication.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.J Virol. 2000 May;74(9):4291-301. doi: 10.1128/jvi.74.9.4291-4301.2000. J Virol. 2000. PMID: 10756044 Free PMC article.
-
In-cell selectivity profiling of membrane-anchored and replicase-associated hepatitis C virus NS3-4A protease reveals a common, stringent substrate recognition profile.Biol Chem. 2011 Oct;392(10):927-35. doi: 10.1515/BC.2011.076. Epub 2011 Jul 13. Biol Chem. 2011. PMID: 21749281
-
Redesigning the substrate specificity of the hepatitis C virus NS3 protease.Fold Des. 1996;1(1):35-42. Fold Des. 1996. PMID: 9079362
-
The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.Antivir Ther. 1998;3(Suppl 3):99-109. Antivir Ther. 1998. PMID: 10726060 Review.
-
Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets.Antivir Ther. 1998;3(Suppl 3):71-81. Antivir Ther. 1998. PMID: 10726057 Review.
Cited by
-
Comparative Analysis of Hepatitis C Virus NS5A Dynamics and Localization in Assembly-Deficient Mutants.Pathogens. 2021 Feb 4;10(2):172. doi: 10.3390/pathogens10020172. Pathogens. 2021. PMID: 33557275 Free PMC article.
-
Pharmacophore-Assisted Covalent Docking Identifies a Potential Covalent Inhibitor for Drug-Resistant Genotype 3 Variants of Hepatitis C Viral NS3/4A Serine Protease.Viruses. 2024 Aug 3;16(8):1250. doi: 10.3390/v16081250. Viruses. 2024. PMID: 39205224 Free PMC article.
-
Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B protein.Antimicrob Agents Chemother. 2013 Jul;57(7):3250-61. doi: 10.1128/AAC.00527-13. Epub 2013 Apr 29. Antimicrob Agents Chemother. 2013. PMID: 23629699 Free PMC article.
-
The GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4+ T lymphocyte cell line without decreasing HIV receptor expression.PLoS One. 2012;7(1):e30653. doi: 10.1371/journal.pone.0030653. Epub 2012 Jan 23. PLoS One. 2012. PMID: 22292009 Free PMC article.
-
NS2 proteases from hepatitis C virus and related hepaciviruses share composite active sites and previously unrecognized intrinsic proteolytic activities.PLoS Pathog. 2018 Feb 7;14(2):e1006863. doi: 10.1371/journal.ppat.1006863. eCollection 2018 Feb. PLoS Pathog. 2018. PMID: 29415072 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources